| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Executive Chairman +1 more
4 companies
Kirk Randal J is a Director, 10% Owner at PRECIGEN, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 7 buys and 36 sells.
Estimated insider holdings value: $489.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 644,998 | $18.08 | $11,663,346.32 | -3.4% | |
| Aug 23, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 1,194,462 | $17.65 | $21,085,138.39 | -5.5% | |
| Aug 16, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 490,072 | $17.30 | $8,476,982.75 | -2.1% | |
| Aug 10, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 572,804 | $17.35 | $9,937,299.04 | -2.2% | |
| Jul 27, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 302,827 | $17.24 | $5,221,414.30 | -1.1% | |
| Jul 3, 2018 | PGEN Precigen, Inc. | Chief Executive Officer | Buy | 7,479,431 | $13.37 | $99,999,992.47 | +33.1% | |
| Jun 29, 2018 | HALO Halozyme Therapeutics, Inc. | 10% Owner | Sell | 304,321 | $17.04 | $5,186,691.92 | -1.1% | |
| Jan 19, 2018 | PGEN Precigen, Inc. | Chief Executive Officer | Buy | 1,000,000 | $12.50 | $12,500,000.00 | +14.7% | |
| Jan 17, 2018 | PGEN Precigen, Inc. | 10% Owner | Buy | 1,538,461 | $3.25 | $4,999,998.25 | +29.8% | |
| Dec 11, 2017 | PGEN Precigen, Inc. | 10% Owner | Buy | 2,727,273 | $0.77 | $2,100,000.21 | +80.1% |